Laboratory and Benchtop Performance of a Mealtime Insulin-Delivery System. (July 2018)

• Record Type: Journal Article
• Authors: Dreon, Darlene M.; Hannon, Trevor M.; Cross, Brett; Carter, Brett J.; Mercer, Nicholas S.; Nguyen, Jason H.; Tran, Andy; Melendez, Peter A.; Morales, Nancy; Nelson, Jonathan E.; Tan, Meng H.
• Is Part Of: Journal of diabetes science and technology. Volume 12:Number 4(2018:Jul.)
• Page Start: 817
• Page End: 827
• Publication Date: 2018-07
• Subjects: diabetes mellitus -- insulin delivery -- injection -- mealtime insulin -- rapid-acting insulin -- insulin dosing; Diabetes -- Periodicals; Medical technology -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462005
• DOI: 10.1177/1932296818760633
• Languages: English
• ISSNs: 1932-2968

Abstract

Background: A basal bolus insulin regimen requires multiple daily insulin injections, which might discourage patient adherence. As a potential solution, a mealtime insulin-delivery system—a 3-day wearable bolus-only patch—was designed to manually administer mealtime insulin discreetly by actuating buttons through clothing, without the need for multiple needle sticks. Method: Extensive functional testing of the patch included dose accuracy (from initial fill of the device to empty), pressure-vacuum leak testing, last-dose lockout and occlusion detection (safety alert features that lock the dosing buttons when no insulin is delivered), assessments of insulin drug stability, toxicological risk (including chemical testing), and system biocompatibility. Results: Dosing accuracy was 2 units ±10% (with U-100 insulin) over a range of environmental conditions, with ≥95% reliability and confidence. The fluid seal performance and the safety alert features performed with ≥95% reliability and ≥95% confidence. The system met acceptable standards for insulin (U-100 lispro and aspart) stability for its intended 3-day use, in addition to the operational requirements. The toxicological risk assessment and demonstrated biocompatibility suggested that the patch is safe for human use. Conclusions: Benchtop performance showed that the bolus-only patch is a safe, accurate, and reliable device for mealtime insulin delivery.